Skip to main content
NUTRACEUTICALS

Continuity billing that actually continues.

Payment infrastructure for supplements, peptides, and wellness brands. Subscription-friendly processors, chargeback prevention, and trial flows that don't trigger instant terminations.

Consulting only: AtlasPayment does not process payments, hold funds, issue accounts, or guarantee provider approval.

Continuity billing that actually continues.
THE CHALLENGE

Subscription model scrutiny

Nutraceutical and supplement businesses operate in one of the most processor-hostile categories. Trial offers, subscription billing, and health claims create a perfect storm of chargeback risk that mainstream processors refuse to touch. Even specialized high-risk processors often terminate after the first spike.

  • ISSUE-001

    Trial and continuity billing models are flagged as 'negative option' by most processors

  • ISSUE-002

    Health and wellness claims trigger regulatory scrutiny and compliance reviews

  • ISSUE-003

    Chargeback rates on subscription renewals exceed thresholds within months

  • ISSUE-004

    Card scheme rules on recurring billing create technical compliance burdens

  • ISSUE-005

    Product category classification varies by processor, creating inconsistent approvals

OUR APPROACH

Continuity-native processing

We build payment infrastructure designed for subscription wellness brands. Processors who understand trial-to-paid conversions, chargeback prevention before disputes become chargebacks, and billing practices that satisfy card scheme requirements.

Product Classification

Product Classification

Proper MCC coding and product categorization that matches your actual business model to appropriate processor risk appetites.

Subscription Management

Subscription Management

Recurring billing infrastructure with proper authorization flows, retry logic, and customer communication that reduces involuntary churn.

Chargeback Prevention

Chargeback Prevention

Alert services, descriptor optimization, and pre-dispute resolution that keeps ratios below termination thresholds.

Continuity Processing

Continuity Processing

Trial-to-paid and subscription renewal flows that satisfy card scheme requirements while maximizing conversion.

HOW WE WORK

Our proven process

From assessment to live infrastructure in 60-90 days.

01

Assessment

Review your product catalog, billing models, and current chargeback patterns to design appropriate processor strategy.

02

Classification

Map products to appropriate risk categories and identify processors with genuine appetite for your specific model.

03

Onboarding

Execute applications with proper documentation, product samples, and marketing compliance materials.

04

Prevention

Implement chargeback prevention, customer service optimization, and billing best practices to maintain accounts.

GET STARTED

Ready to build resilient payment infrastructure?

A 30-minute confidential call with a senior architect. No sales scripts — you leave with one concrete structural recommendation.

Consulting does not guarantee provider approval. Fees are disclosed before engagement begins.

Prefer async?

Write us at support@atlaspayment.org with the shape of the problem. A senior architect replies within 24 hours. AtlasPayment is operated by LUNVEXIS LIMITED.

  • support@atlaspayment.org
  • LUNVEXIS LIMITED
  • Room 511, 5/F, Ming Sang Ind Bldg, 19-21 Hing Yip Street, Kwun Tong, Hong Kong
FAQ

Common questions

Everything you need to know about our continuity billing that actually continues services.

Three factors compound: subscription/continuity billing models that generate higher chargeback rates, health claims that trigger regulatory scrutiny, and product categories that some processors blanket-ban. Most operators are rejected not for fraud but for business model characteristics that mainstream processors don't want to underwrite.
Yes, though CBD requires specialized processor relationships and careful compliance documentation. The landscape has improved significantly, but processor requirements vary widely. We match your specific product type (isolate, broad-spectrum, full-spectrum) with processors who have clear policies for that category.
These models require processors who explicitly accept 'negative option' billing and understand trial-to-paid conversion flows. We structure billing practices, customer communication, and cancellation processes to satisfy both processor requirements and card scheme rules on recurring consent.
Industry baseline for subscription supplements is 1.5-3% without intervention. With proper prevention infrastructure — alerts, descriptor optimization, proactive customer service — we typically see clients maintain 0.8-1.2%. The goal is staying comfortably below the 1% threshold that triggers processor scrutiny.
Yes, we build processing infrastructure for brands selling into US, EU, UK, and other markets. Geographic routing, multi-currency settlement, and jurisdiction-appropriate compliance are core to our approach. International operations often benefit from entity structuring that matches processor preferences.